Innate lymphoid cells: New players in atherosclerosis?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 12, 2013, Pages 2697-2698

  Tedgui, Alain ^a,b   Ait Oufella, Hafid ^a,c  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD5 ANTIGEN; IMMUNOGLOBULIN M; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7; LEUKOSIALIN; LOW DENSITY LIPOPROTEIN; PHOSPHORYLCHOLINE; TRANSCRIPTION FACTOR GATA 3;

ADAPTIVE IMMUNITY; ALLERGY; ASTHMA; ATHEROSCLEROTIC PLAQUE; B LYMPHOCYTE; CELLS; EDITORIAL; ENDOTHELIAL MICROPARTICLE; HYPERCHOLESTEROLEMIA; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOID CELL; NATURAL KILLER CELL; NONHUMAN; ORGANOGENESIS; PARASITOSIS; PRIORITY JOURNAL; TH2 CELL; WILD TYPE; WOUND HEALING;

ADAPTIVE IMMUNITY; ATHEROCLEROSIS; INNATE IMMUNITY;

ANIMALS; AORTA; AORTIC DISEASES; ATHEROSCLEROSIS; B-LYMPHOCYTE SUBSETS; CELL PROLIFERATION; IMMUNITY, INNATE; INHIBITOR OF DIFFERENTIATION PROTEINS; INTERLEUKIN-5; MALE;

EID: 84888145701     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.302607     Document Type: Editorial

References (14)

1. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: Regulators and effectors of immunity and tissue remodeling. Nat Immunol. 2011;12:21-27
2. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S. Innate production of T(H)2 cytokines by adipose tissue-Associated c-Kit(+)Sca-1(+) lymphoid cells. Nature. 2010;463:540-544
3. Saenz SA, Siracusa MC, Perrigoue JG, Spencer SP, Urban JF Jr, Tocker JE, Budelsky AL, Kleinschek MA, Kastelein RA, Kambayashi T, Bhandoola A, Artis D. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature. 2010;464:1362-1366
4. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R, Jolin HE, McKenzie AN. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010;464:1367-1370
5. Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A. 2010;107:11489-11494
6. Perry HM, Oldham SN, Fahl SP, Que X, Gonen A, Harmon DB, Tsimikas S, Witztum JL, Bender TP, McNamara CA. Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation. Arterioscler Thromb Vasc Biol, 2013;33:2771-2779
7. Binder CJ, Hartvigsen K, Chang MK, Miller M, Broide D, Palinski W, Curtiss LK, Corr M, Witztum JL. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest. 2004;114:427-437
8. Doran AC, Lehtinen AB, Meller N, Lipinski MJ, Slayton RP, Oldham SN, Skaflen MD, Yeboah J, Rich SS, Bowden DW, McNamara CA. Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans. Circ Res. 2010;106:1303-1311
9. Doran AC, Lipinski MJ, Oldham SN, et al. B-cell aortic homing and atheroprotection depend on Id3. Circ Res. 2012;110:e1-12
10. Miller AM, Xu D, Asquith DL, Denby L, Li Y, Sattar N, Baker AH, McInnes IB, Liew FY. IL-33 reduces the development of atherosclerosis. J Exp Med. 2008;205:339-346
11. Nussbaum JC, Van Dyken SJ, von Moltke J, Cheng LE, Mohapatra A, Molofsky AB, Thornton EE, Krummel MF, Chawla A, Liang HE, Locksley RM. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature. 2013;502:245-248
12. Lefrançais E, Cayrol C. Mechanisms of IL-33 processing and secretion: Differences and similarities between IL-1 family members. Eur Cytokine Netw. 2012;23:120-127
13. Leroyer AS, Isobe H, Lesèche G, Castier Y, Wassef M, Mallat Z, Binder BR, Tedgui A, Boulanger CM. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol. 2007;49:772-777
14. Lahoute C, Herbin O, Mallat Z, Tedgui A. Adaptive immunity in atherosclerosis: Mechanisms and future therapeutic targets. Nat Rev Cardiol. 2011;8:348-358